Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
about
Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myelomaCancer Therapy Due to Apoptosis: Galectin-9.miR-455-5p functions as a potential oncogene by targeting galectin-9 in colon cancer.Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair.Lectins: production and practical applications.A lectin with highly potent inhibitory activity toward breast cancer cells from edible tubers of Dioscorea opposita cv. nagaimoHalofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infectionGalectins as therapeutic targets for hematological malignancies: a hopeful sweetness.The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.Development and Applications of Lectins as Biological Tools in Biomedical Research.Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells.Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance.Galectin-9: From cell biology to complex disease dynamics.Molecular characterization of T-cell immunoglobulin mucin domain-3 and Galectin-9 genes of swamp- and riverine-type water buffaloes.Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5.Role of Galectins in Multiple Myeloma.Role of Galectins in Tumors and in Clinical Immunotherapy.Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.The Role of Galectins in Cervical Cancer Biology and Progression.Multiple Roles of Glycans in Hematological MalignanciesExtracellular galectins as controllers of cytokines in hematological cancer
P2860
Q28479002-54331E93-6FC4-40C9-BABC-8BA5D581B493Q30397015-8BFD5B34-7305-4EEE-BB19-F46FE3EB53A8Q33598659-864DDDDB-E166-4AD0-9CA0-9AA944BF8B06Q33897793-BC361281-4B97-447F-9B12-92EB61FD2A39Q34467718-D7509672-CEFF-4F34-9D17-E740E53C13A5Q34562758-7DDD68A2-1C08-4DA6-9F48-F1129AEE02D5Q35552714-B422C6A9-B632-4E1B-82EC-97F225195194Q35986628-FB7CF97F-4782-45FA-8E05-206E39E3B6AFQ38269046-D9093189-11FD-4B4A-80A1-35DCBCEDBE55Q38373689-19BE8FB5-55B0-4A63-A8C9-41C4571BBF77Q38569847-2BE9C275-1D26-48AD-9A32-D32C09A26E7FQ38744898-2A7343CE-9D12-4973-B5C9-86A8A442B2E5Q38764048-EA9F8A4A-7B4C-4312-9F29-A565DCB2DB37Q38810089-717FACE2-D3C3-4748-9E62-7803B205EB60Q38833807-F911BAA6-7727-4EA0-A39A-456C7447BBD1Q38942909-4907308A-74D2-467F-AECD-70B4C190A33DQ40461629-C28BAEC0-395C-4F6C-9677-5893DCB96B7FQ41168758-4EB49EDC-2E28-412D-B175-1CF2F5EDE662Q45884221-7A8E5F5A-2FBF-4A90-B7CB-0A40ABCE152BQ47282400-B517AEE5-9918-4BC8-979C-49AC5330BA91Q48124343-42BB0E7A-4CA0-478C-BE95-9EA50F975D63Q48236958-4A550965-DE7D-4550-906E-5F8A7F67F511Q50224538-AD17CF38-B841-4995-9536-12FEDC9F03A8Q54968635-CAFD0D63-C9A5-4F82-90FC-4D29C219255CQ55152503-25E3BCA8-C31E-4CFC-8270-FB8930A3A1ABQ58761454-788583FC-2526-4B0D-9E0B-0F3F6C0C511CQ58803547-1D61299B-E5C5-4A40-B389-397FC5302572
P2860
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@en
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@nl
type
label
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@en
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@nl
prefLabel
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@en
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@nl
P2093
P2860
P356
P1433
P1476
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
@en
P2093
A Taniyama
A Yamauchi
E Ashihara
M Hirashima
M Taniwaki
M Yamamoto
P2860
P2888
P304
P356
10.1038/LEU.2010.25
P577
2010-03-04T00:00:00Z